chr5-56874986-C-G
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005921.2(MAP3K1):c.1687-46C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0692 in 1,599,424 control chromosomes in the GnomAD database, including 4,073 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.059 ( 284 hom., cov: 32)
Exomes 𝑓: 0.070 ( 3789 hom. )
Consequence
MAP3K1
NM_005921.2 intron
NM_005921.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.453
Genes affected
MAP3K1 (HGNC:6848): (mitogen-activated protein kinase kinase kinase 1) The protein encoded by this gene is a serine/threonine kinase and is part of some signal transduction cascades, including the ERK and JNK kinase pathways as well as the NF-kappa-B pathway. The encoded protein is activated by autophosphorylation and requires magnesium as a cofactor in phosphorylating other proteins. This protein has E3 ligase activity conferred by a plant homeodomain (PHD) in its N-terminus and phospho-kinase activity conferred by a kinase domain in its C-terminus. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 5-56874986-C-G is Benign according to our data. Variant chr5-56874986-C-G is described in ClinVar as [Benign]. Clinvar id is 1231698.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.11 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP3K1 | NM_005921.2 | c.1687-46C>G | intron_variant | Intron 9 of 19 | ENST00000399503.4 | NP_005912.1 | ||
MAP3K1 | XM_047417218.1 | c.1687-46C>G | intron_variant | Intron 9 of 17 | XP_047273174.1 | |||
MAP3K1 | XM_047417219.1 | c.1276-46C>G | intron_variant | Intron 10 of 20 | XP_047273175.1 | |||
MAP3K1 | XM_047417220.1 | c.1276-46C>G | intron_variant | Intron 10 of 20 | XP_047273176.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0593 AC: 9017AN: 152122Hom.: 284 Cov.: 32
GnomAD3 genomes
AF:
AC:
9017
AN:
152122
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0664 AC: 16411AN: 246970Hom.: 607 AF XY: 0.0662 AC XY: 8868AN XY: 134038
GnomAD3 exomes
AF:
AC:
16411
AN:
246970
Hom.:
AF XY:
AC XY:
8868
AN XY:
134038
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0702 AC: 101636AN: 1447184Hom.: 3789 Cov.: 29 AF XY: 0.0700 AC XY: 50445AN XY: 720894
GnomAD4 exome
AF:
AC:
101636
AN:
1447184
Hom.:
Cov.:
29
AF XY:
AC XY:
50445
AN XY:
720894
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0592 AC: 9018AN: 152240Hom.: 284 Cov.: 32 AF XY: 0.0596 AC XY: 4433AN XY: 74418
GnomAD4 genome
AF:
AC:
9018
AN:
152240
Hom.:
Cov.:
32
AF XY:
AC XY:
4433
AN XY:
74418
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
259
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Nov 12, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
46,XY sex reversal 6 Benign:1
Nov 05, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at